Details of the Drug Reposition

General Information of This Drug (ID: DMGU74E)

Drug Name
Cholecalciferol   DMGU74E
Synonyms
Arachitol; Calciol; Cholecalciferolum; Colecalciferol; Colecalciferolo; Colecalciferolum; Colecalcipherol; Delsterol; Deparal; Ebivit; FeraCol; Provitamine; Provitina; Rampage; Ricketon; Trivitan; Vigorsan; Colecalciferolo [DCIT]; VITAMIN D; Duphafral D3 1000; LT00244775; NEO Dohyfral D3; Oleovitamin D3; TNP00266; VITAMIN D3 POWDER; VITAMIN_D3; Vitamin D3; Vitamin D3 emulsifiable; Activated 7-dehydrocholesterol; Cholecalciferol (D3); Cholecalciferol, D3; Colecalciferol (INN); Colecalciferolum [INN-Latin]; D3-Vicotrat; D3-Vigantol; Delta-D; Irradiated 7-dehydrocholesterol; Micro-dee; Vitamin d-3; Cholecalciferol (JP15/USP); Cholecalciferol [USAN:BAN:JAN]; Delta-D (TN); Vitinc Dan-Dee-3; Vi-de-3-hydrosol; (+)-Vitamin D3; (3S,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol; (3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol; (5Z,7E)-(3S)-9,10-seco-5,7,10(19)-cholestatrien-3-ol; (5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-trien-3-ol; 25(OH)D; 7-Dehydrocholesterol activated; 7-Dehydrocholesterol, Activated; 7-Dehydrocholesterol, irradiated; 7-Dehydrocholestrol, activated; 9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3-ol; 9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3beta-ol; 9,10-Secocholesta-5(Z),7(E),10(19)-trien-3(beta.)-ol; 9,10-Secocholesta-5,7,10(19)-trien-3-beta-ol
Therapeutic Class
Vitamins
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
13 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Vitamin D-dependent rickets DISC3UAJ N.A. Approved [1]
Primary hyperparathyroidism DISB4U1Q N.A. Approved [1]
Pleural tuberculosis DISD09EG N.A. Approved [1]
Exostosis DIS3VKEI N.A. Approved [1]
Adult acute monocytic leukemia DISG6BLX N.A. Approved [1]
Coronavirus Disease 2019 (COVID-19) DISM7GNX 1D6Y Approved [2]
Hypoparathyroidism DISICS0V 5A50 Approved [1]
Vitamin deficiency DISD07I9 5B55-5B71 Approved [1]
Rickets DISH89YF 5B57 Approved [1]
Hypercalcaemia DISKQ2K7 5B91.0 Approved [1]
Hyperlipidemia DIS61J3S 5C80.Z Approved [1]
Schizoaffective disorder DISLBW6B 6A21 Approved [1]
Osteoporosis DISF2JE0 FB83.0 Approved [1]
------------------------------------------------------------------------------------
⏷ Show the Full List of 13 Indications(s)
1 Discontinued in Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Schizophrenia DISSRV2N 6A20 Discontinued in Phase 3 [3]
------------------------------------------------------------------------------------

References

1 Cholecalciferol FDA Label
2 Cholecalciferol to Improve the Outcomes of COVID-19 Patients (CARED)
3 Udenafil Therapy to Improve Symptomatology, Exercise Tolerance and Hemodynamics in Patients With Chronic Systolic Heart Failure